New Report: Reimbursement Systems for Wound Care Products in Selected European Countries
We’re excited to introduce our latest report, providing key insights into the complex landscape of reimbursement systems across Europe. This first edition covers 13 European countries, highlighting key differences in policies, healthcare settings, and regional frameworks. 🌍 Countries covered: 🇧🇪 Belgium | 🇧🇦 Bosnia & Herzegovina | 🇫🇮 Finland | 🇬🇷 Greece | 🇭🇺 Hungary […]
Clinicgram Investment Webinar with CEO Ibon Uribe
Clinicgram Investment Webinar with CEO Ibon Uribe Clinicgram, a Barcelona-based health tech startup currently is raising €2M in funding. This 30-minute session with CEO Ibon Uribe offers insights into an innovative investment opportunity in the rapidly growing field of chronic wound management. Watch the webinar here.
Registration Open for EWMA Innovation Forum 2025, 27 March, Barcelona
Registration is Now Open for the EWMA Innovation Forum 2025, 27 March, Barcelona! Are you seeking: 🌟 Expert Guidance🤝 Strategic Partnerships💡 New Solutions💰 Investment Opportunities Then look no further. The EWMA Innovation Alliance is hosting the Innovation Forum to foster a collaborative environment aimed at advancing the development of innovative wound healing products from “bench […]
Andrew Cameron, FeelTect: The award-winning Tight Alright technology
In this exclusive video interview, Andrew Cameron, founder of FeelTect, shares the story behind their award-winning Tight Alright technology, designed to revolutionise compression therapy for wound care. Since winning the EWMA Innovation Competition in 2023, we were eager to learn what’s happened next. Key takeaways from the conversation include: Redefining guidelines with evidence-based data analytics […]
Open for proposals: EWMA Innovation Competition 2025
The annual EWMA Innovation Competition aims to support start-ups and spin-outs within wound healing (therapeutics, medtech, diagnostics, AI, service providers etc) helping them bring their solutions to the market for the benefit of patients. We are seeking approaches that have the potential to enhance the quality of wound care while reducing the cost and complexity […]
Interview with Jeremy Elser, CEO of Ship of Theseus
Excited to share our conversation with Jeremy Elser, founder and CEO of Ship of Theseus, a pioneering biotechnology company. Jeremy recently won the EWMA Innovation Competition, and in this interview, he shares insights into his journey, their groundbreaking work in wound care, and the future of Ship of Theseus. Key takeaways from the interview: 🌍 […]
Boost Your Investor Attraction Assisted By The Alliance
EWMA Innovation Alliance is here to help companies attract investments. Our extensive network connects you with venture capitalists, business angels, family offices, business developers, and experts in venture and M&A from leading companies. Download our investor attraction flyer by clicking on the picture. Contact UsTo arrange a consultation contact us at innovation@ewma.org
Download the New European Wound Care Market Entry Consultancy flyer
Navigating the European market for wound care products can be daunting due to its complex regulatory, clinical, and commercial requirements. To succeed, you need precise, wound expert guidance. That’s where the EWMA Innovation Alliance comes in. Our team, composed of seasoned wound care industry professionals and key opinion leaders (KOLs), offers expertise and assistance in several […]
Elevate Your Team’s Expertise with EIA Wound Academy
Are you seeking comprehensive training solutions for your team on regulatory requirements, quality management, and clinical trial processes within the wound care industry? Look no further. At EIA, we offer tailored programs to wound care companies. Our training is available both onsite and online. Why Choose EIA for Staff Training? Expert Instructors: Our courses are […]
Investor Opportunities in Wound Care
Are you developing a wound care solution that meets the following criteria? Based in Continental Europe Early-stage (Seed/Series A; Discovery through First-in-Human studies) Focused on therapeutics (drug development) Addressing an unmet medical need If so, we are connected with an investor keen to review your pitch deck. For more information, please contact us at […]